nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS1—Ifosfamide—testicular cancer	0.311	0.311	CbGbCtD
Lornoxicam—PTGS2—Cisplatin—testicular cancer	0.179	0.179	CbGbCtD
Lornoxicam—PTGS2—Etoposide—testicular cancer	0.176	0.176	CbGbCtD
Lornoxicam—PTGS1—Etoposide—testicular cancer	0.149	0.149	CbGbCtD
Lornoxicam—CYP2C9—Ifosfamide—testicular cancer	0.125	0.125	CbGbCtD
Lornoxicam—CYP2C9—Cisplatin—testicular cancer	0.0608	0.0608	CbGbCtD
